Financing, Equity Capital Markets

Arrowhead Pharmaceuticals, Inc.

12/19
|
$266.8 Million
Piper Sandler served as bookrunner for Arrowhead Pharmaceuticals, Inc. on a follow-on offering
Sub-Type
Follow-On Offering
Sub-Sector
Biopharma